US Patent Issued to SCHRODINGER on July 21 for "Heterocyclic pericondensed CDC7 kinase inhibitors for the treatment of cancer" (New Jersey, New York, Oregon, California Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,688, issued on July 21, was assigned to SCHRODINGER INC. (N.Y.).

"Heterocyclic pericondensed CDC7 kinase inhibitors for the treatment of cancer" was invented by Xianhai Huang (Warren, N.J.), Sayan Mondal (La Jolla, Calif.), Phani Ghanakota (Edison, N.J.), Nicholas Boyles (Hillsboro, Ore.), Leah Frye (Portland, Ore.), Adam Levinson (Bronx, N.Y.), Jeremy Robert Greenwood (Brooklyn, N.Y.), Pieter Bos (New York), Sathesh Bhat (New York), Aleksey Gerasyuto (Flemington, N.J.) and Haifeng Tang (Metuchen, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application relates to compounds of Formula (I), as defined herein, and pharmaceutically a...